It is April 25, 2026, and the global financial markets have officially transitioned from being driven by traditional economic indicators like the CPI or unemployment rates to a much more volatile metric: the “Midnight Truth.” As of this morning, investors are once again scrambling to recalibrate their portfolios after a flurry of announcements from President Donald Trump that managed to touch on everything from Middle Eastern energy flows to the therapeutic benefits of psychedelics and the geopolitical status of the Falkland Islands. It’s a busy time for anyone who enjoys sleeping, but a lucrative one for high-frequency trading algorithms programmed to detect the specific syntax of a presidential caps-lock binge.
The primary mover in the pre-market session has been the President’s announcement of a 90-day reprieve for energy flows through the Strait of Hormuz. In a move that surprised exactly no one who has followed the administration’s “maximum pressure, minimum consistency” policy, Trump declared that energy shipments would remain unmolested for another three months despite what he termed “Hormuz jitters.” The reaction in the energy sector was immediate. Crude oil futures, which had been flirting with triple digits, took a sudden dive. West Texas Intermediate (WTI) fell 3.4% to $94.12, while Brent Crude slipped 2.8% to settle near $97.05. For those keeping score at home, this 90-day window provides just enough time for the market to price in a resolution before the next inevitable threat of a blockade sends prices back into the stratosphere.
The Ceasefire That Wasn’t (But Sort of Was)
In the realm of diplomacy—or what currently passes for it—Trump announced a three-week extension of the Israel-Lebanon truce. This announcement, delivered via DJT (-4.2%), was met with the usual mixture of relief and profound confusion. While the President touted the extension as a masterclass in negotiation, the actual reality on the ground was a bit more “kinetic.” Reports surfaced almost immediately of Israeli strikes in Lebanon following the announcement, leading to a rather awkward “mixed” trading session for U.S. futures. The Dow Jones Industrial Average futures slipped 0.4%, while the S&P 500 remained flat, as traders tried to determine if a “ceasefire” includes or excludes active bombardment. It appears the market has decided that as long as the announcement exists, the reality is a secondary concern.
The volatility wasn’t limited to the Middle East. The President also took time to “fly off the handle” at a reporter regarding the timeline of a potential war with Iran. While the White House press corps dodged verbal shrapnel, the defense sector saw a curious spike in volume. LMT (+1.1%) and RTX (+0.9%) both saw pre-market gains as the “defensive mood” in the Oval Office usually translates to “offensive spending” in the Pentagon. Analysts at Goldman Sachs noted that “geopolitical uncertainty remains the primary driver of alpha,” which is a polite way of saying that nobody has any idea what’s going to happen next, but it’s going to be expensive.
Big Pharma and the Art of the “Reverse Pay”
Perhaps the most fascinating development of the last 24 hours is the deal struck with REGN (+2.3%). In a move that Commerce Secretary Howard Lutnick tied directly to the administration’s tariff policies, Regeneron has agreed to “most-favored-nation” drug pricing for American patients. In exchange, the company received manufacturing commitments and, presumably, a reprieve from the looming threat of 25% tariffs on imported chemical precursors. This “tariffs-for-tinctures” trade is a new pillar of the administration’s economic policy: use the threat of a trade war to lower the price of Eylea. It’s a bold strategy, and one that has PFE (-0.5%) and ABBV (-0.8%) looking nervously at their own supply chains.
Adding to the corporate drama, the President has reportedly begun pressuring companies not to claim the tariff refunds they are legally entitled to. Described by some as a “reverse pay” system, the administration is essentially asking American businesses to treat their overpaid taxes as a “donation to greatness.” While the legalities of this are being debated in the D.C. Circuit Court—which recently blocked a key pillar of the administration’s migration policy—the market reaction has been one of quiet compliance. Most CEOs have realized that a 2.3% hit to the bottom line from unclaimed refunds is preferable to a 100% hit to their reputation via a presidential “Truth” at 2:00 AM.
The Global Tariff Tour: London, Ottawa, and the Moon
Not content with domestic disruption, the President has turned his sights on the United Kingdom. Prime Minister Keir Starmer was threatened with a “big tariff” over the UK’s proposed digital services tax on U.S. tech giants. The threat sent the British Pound tumbling 0.6% against the dollar, while shares of AAPL (+1.2%) and GOOGL (+0.8%) rose on the news that the U.S. government is effectively acting as their global collection agency. The irony of a populist administration fighting to protect the margins of Silicon Valley’s elite was not lost on the markets, but as long as the shipments of iPhones to China remain up 20% in Q1, the contradictions are easily ignored.
The tariff threats didn’t stop at the Atlantic. Canada’s Mark Carney also found himself in the crosshairs, with Trump dismissing Canadian trade concerns as “more than irritants.” Meanwhile, in a move that feels like a plot point from a low-budget sci-fi movie, the U.S. and China are now reportedly competing for a “foothold on the moon.” While MSFT (+0.4%) and GOOGL (+0.8%) are busy bidding to lease SoftBank data centers on Earth, the administration is focused on “industrial-scale” AI secrets and lunar real estate. The NASDAQ, heavy with tech and aerospace, rose 0.7% on the prospect of a subsidized space race, proving once again that the only thing the market loves more than a trade war is a literal star war.
Psychedelics, Hemp, and the White House Beehive
In a final, surreal twist to the week’s events, the FDA has announced an “ultra-fast review” of three psychedelic drugs following a direct presidential directive. This follows Trump’s call for Congress to amend the hemp ban and expand access to CBD products. Apparently, the administration has decided that the best way to handle the stress of a potential war with Iran and a trade war with the UK is to ensure the American public has ready access to high-grade hallucinogens and full-spectrum tinctures. Cannabis-related stocks like CGC (+12.4%) and TLRY (+8.7%) saw massive volume spikes, as investors bet on a future where the “vibe economy” is the only economy left.
As the week closes, Melania Trump has announced the addition of a new beehive to the White House grounds. While the market impact of “First Lady Honey” is expected to be minimal, the metaphor is hard to miss. The administration has successfully turned the global economy into a giant, buzzing hive of activity where everyone is working frantically, the queen is occasionally erratic, and everyone is constantly at risk of getting stung. But hey, as long as INTC (+6.5%) is having its best day since 1987, who are we to complain about a little bit of smoke in the hive?
DISCLAIMER: We read Trump’s posts so you don’t have to. This is comedy meets market data, not financial advice. Not political advice either – we just like charts and chaos.
Elana Harper is a seasoned financial editor and market analyst with over a decade of experience covering global equities, economic trends, and corporate earnings. Known for her sharp insights, Elana specializes in making complex financial topics accessible to a broad audience. She now serves as the Senior Financial Editor at Stock Market Watch, where she oversees daily market coverage and political commentary.